abstract |
The present invention includes a method and related compositions to modulate myeloid-derived suppressor cell (MDSC) suppressive function, MDSC differentiation, or combinations thereof in a cancer patient by administering a yeast comprising β-glucans to the cancer patient, in which the yeast can be modified to unmask yeast cell wall β-glucans to enhance the effect on MDSCs. |